Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice

NCT03708367 is registered in ClinicalTrials.gov with Johnson & Johnson Surgical Vision, Inc. as lead sponsor.

NCT NCT03708367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03708367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
Lead sponsor
Johnson & Johnson Surgical Vision, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 16, 2018
Completion date
January 13, 2020
Enrollment
117 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cataracts, meibomian gland dysfunction (mgd)